Paper6232086
Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.
Arbeit RD and 3 others. Diagn Microbiol Infect Dis, 1984. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Papers, record 6232086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6232086
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polysaccharides, Bacterial | Major topic |
| Staphylococcus aureus | Major topic |
| Antigens, Bacterial | |
| Humans | |
| Sepsis | |
| Serotyping | |
| Staphylococcal Infections | |
| Staphylococcus Phages |
Source PubMed
Cited by72
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41170422 | Bacterial and host interactions in Staphylococcus aureus-induced septic arthritis-understanding pathogenesis and exploring therapeutic strategies. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41170422 | PubMed |
| 35129409 | Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials. | Expert Opin Investig Drugs | 2022 | https://conductscience.org/library/papers/35129409 | PubMed |
| 31736914 | Comparative Genome Analysis of Staphylococcus lugdunensis Shows Clonal Complex-Dependent Diversity of the Putative Virulence Factor, ess/Type VII Locus. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31736914 | PubMed |
| 31190912 | Recent advances in Staphylococcus aureus infection: focus on vaccine development. | Infect Drug Resist | 2019 | https://conductscience.org/library/papers/31190912 | PubMed |
| 29941424 | MsaB and CodY Interact To Regulate Staphylococcus aureus Capsule in a Nutrient-Dependent Manner. | J Bacteriol | 2018 | https://conductscience.org/library/papers/29941424 | PubMed |
| 28422567 | Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection. | Hum Vaccin Immunother | 2017 | https://conductscience.org/library/papers/28422567 | PubMed |
| 28239370 | capB2 Expression Is Associated with Staphylococcus aureus Pathogenicity. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28239370 | PubMed |
| 27213458 | Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses. | Vaccines (Basel) | 2016 | https://conductscience.org/library/papers/27213458 | PubMed |
| 26781313 | MsaB activates capsule production at the transcription level in Staphylococcus aureus. | Microbiology (Reading) | 2016 | https://conductscience.org/library/papers/26781313 | PubMed |
| 25852165 | USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. | mBio | 2015 | https://conductscience.org/library/papers/25852165 | PubMed |
| 25245803 | Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates. | Infect Immun | 2014 | https://conductscience.org/library/papers/25245803 | PubMed |
| 24998740 | Models matter: the search for an effective Staphylococcus aureus vaccine. | Nat Rev Microbiol | 2014 | https://conductscience.org/library/papers/24998740 | PubMed |
| 24753256 | The capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymes. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24753256 | PubMed |
| 23658268 | Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy. | J Clin Microbiol | 2013 | https://conductscience.org/library/papers/23658268 | PubMed |
| 22754017 | Comparison of Capsular Typing of Staphylococcus aureus with Bacteriophage Typing: A Study in Gulbarga, India. | Indian J Microbiol | 2011 | https://conductscience.org/library/papers/22754017 | PubMed |
| 21501445 | An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children. | BMC Public Health | 2011 | https://conductscience.org/library/papers/21501445 | PubMed |
| 20065327 | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. | Clin Microbiol Rev | 2010 | https://conductscience.org/library/papers/20065327 | PubMed |
| 19185345 | Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials. | Biomaterials | 2009 | https://conductscience.org/library/papers/19185345 | PubMed |
| 18540063 | Expression, purification, crystallization and preliminary diffraction analysis of CapF, a capsular polysaccharide-synthesis enzyme from Staphylococcus aureus. | Acta Crystallogr Sect F Struct Biol Cryst Commun | 2008 | https://conductscience.org/library/papers/18540063 | PubMed |
| 17893153 | Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17893153 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6232086
GET https://conductscience.org/api/papers/v1/6232086/cited_by?page=2